Mammalian cell fermentation technology is driving the production of biological medicines, meeting growing demand with pipeline expansion, supportive regulations, and investments in personalized medicine manufacturing capabilities
NEWARK, Del., April 23, 2024 (Globe Newswire) — Mammalian cell fermentation technology market is estimated to be valuable $45.9 billion In 2024, it is predicted to be valued at: 68 billion USD From 2024 to 2034, the industry is expected to register a CAGR of: Ten%.
The rising prevalence of chronic diseases and aging populations around the world are increasing the demand for biopharmaceuticals such as monoclonal antibodies, vaccines, and therapeutic proteins, which are primarily produced using mammalian cell fermentation technology. is produced.
The expanding pipeline of biological medicines, including novel therapeutics and biosimilars, is increasing the demand for mammalian cell fermentation technology to produce them. Increasing number of biologics approvals and clinical trials are further contributing to the market growth.
Request a sample of this report today. https://www.futuremarketinsights.com/reports/sample/rep-gb-19233
Regulatory authorities around the world have established clear guidelines and standards for the development, manufacturing, and approval of biopharmaceuticals produced using mammalian cell fermentation technology. This supportive regulatory environment ensures product quality, safety, and efficacy and fosters market growth.
Pharmaceutical companies, biotechnology companies, and contract manufacturing organizations (CMOs) are investing heavily in expanding their biopharmaceutical manufacturing capabilities. This includes investments in bioreactor systems, infrastructure, and expertise to drive market growth.
The shift towards personalized medicine and targeted therapies is leading to the development of biologics tailored to individual patient profiles. Mammalian cell fermentation technology enables the production of personalized biologics, driving market growth in this emerging field.
Key takeaways from the Mammalian Cell Fermentation Technology Market:
-
From 2019 to 2023, the mammalian cell fermentation technology market expanded at a CAGR. 11.4%.
-
Based on type, the Chinese hamster ovary (CHO) cell fermentation segment is expected to rise at a CAGR. 3.8% Until 2034.
-
The demand for mammalian cell fermentation technology in China is projected to grow at a CAGR. 4.8% Until 2034.
-
In the United States, the mammalian cell fermentation technology industry is estimated to record a CAGR. 4.2% From 2024 to 2034.
-
The UK is expected to expand at a CAGR. 5.0% Between 2024 and 2034.
-
The Japanese mammalian cell fermentation technology market is 5.5% In 2034.
“The combination of increasing demand for biopharmaceuticals, advances in biotechnology, supportive regulatory environment, and technological innovations are the key drivers driving the growth of the mammalian cell fermentation technology market. ” To tell Sabyasachi Ghosh (Vice President, Future Market Insights, Inc.).
Click here to request the methodology! https://www.futuremarketinsights.com/request-report-methodology/rep-gb-19233
Competitive environment of the mammalian cell fermentation technology market:
Market players prioritize customer satisfaction by providing customized solutions, technical support, and responsive customer service. Understanding customer needs, providing timely assistance, and fostering long-term relationships are essential to building brand loyalty and gaining a competitive advantage in the market.
-
In October 2023, Vaxcyte, Inc. and Lonza announced a new commercial manufacturing partnership, building on their continued collaboration. The agreement will facilitate the worldwide distribution of Vaxcyte's PCV candidates, namely his VAX-24 and VAX-31, to address both adult and pediatric populations.
-
The partnership, which leverages Lonza's existing infrastructure, is expected to advance clinical development efforts and pave the way for the planned initial release of VAX-24 for adult use in the United States.
Major companies introduced in Mammalian cell fermentation technology market:
Click here to purchase the full report https://www.futuremarketinsights.com/checkout/19233
Mammalian Cell Fermentation Technology Market – Key Segments
By type:
-
Chinese hamster ovary (CHO) cell fermentation
-
Human embryonic kidney (HEK) cell fermentation
-
Baby hamster kidney (BHK) cell fermentation
-
Fermentation of mouse myeloma cells
-
Other types
By application:
-
monoclonal antibody
-
recombinant protein
-
vaccine
-
hormone
-
enzyme
-
Other uses
By end use:
By region:
About the healthcare sector At Future Market Insights
Future Market Insights' healthcare team provides expert analysis, time-efficient research, and strategic recommendations to deliver authentic insights and accurate results to help clients across the globe . With over 100 reports and over 1 million data points, our team has been clearly analyzing industries in over 50 countries for over 10 years. The team briefly analyzes key trends such as the competitive environment, profit margins, and R&D efforts.
author
Sabyasachi Ghosh (Vice President, Future Market Insights, Inc.) has over 12 years of experience in the healthcare, medical device, and pharmaceutical industries. His curiosity and analytical skills helped shape his career as a researcher.
It comes naturally to him to identify the key challenges faced by his clients and develop robust, hypothesis-based solutions to empower them with strategic decision-making capabilities. His main expertise lies in the areas of market entry and expansion strategies, feasibility studies, competitive intelligence, and strategic transformation.
Sabyasachi, who holds a degree in microbiology, has authored numerous publications and has been cited in journals such as The Journal of mHealth, ITN Online, and Spinal Surgery News.
Check out related reports on the Mammalian Cell Fermentation Technology Market.
The global mammalian protein market is expected to grow to USD 1.5 billion by 2032, from a valuation of USD 588.9 million in 2021.
The global mammalian transient protein expression market is expected to register a CAGR of 8.5% from 2023 to 2033. The market size is expected to reach a valuation of USD 697.2 million in 2023. By 2033, the valuation is expected to reach USD 1,581.6 million.
The global microbial fermentation technology market is estimated to be USD 32,729.05 million in 2023. The demand for microbial fermentation technology is expected to grow at a CAGR of 5.7% and exceed USD 56,974.87 million by 2033.
The cell collection systems market is expected to grow from USD 6.3 billion in 2022 to USD 19.1 billion by 2032. Demand is expected to grow at a significant CAGR of 12.6% during the forecast period.
The global cell line development services market demand is expected to be USD 6,365.2 million in 2023. The overall market is projected to grow at a CAGR of 7.4% from 2023 to 2033.
The global cell culture incubator market was valued at USD 2,315.5 million in 2023 and is projected to reach USD 4,305.1 million by 2033. From 2023 to 2033, the market is expected to grow at a CAGR of 6.4%
The Cell Culture Media Market was valued at USD 3,513.8 million in 2024 and is projected to reach USD 6,699.93 million by 2034. The market is expected to expand at a CAGR of 6.66% during the forecast period.
The cell culture sampling equipment market is expected to grow at a steady CAGR of 10.8% from 2023 to 2033. This market is expected to hold a market share of USD 7.8 billion by 2033.
The global cell therapy manufacturing market size is expected to reach a valuation of USD 4,134.48 million in 2023 and is expected to further expand at a CAGR of 14.2% from 2023 to 2033. End of 2033.
The cell and gene therapy manufacturing market analysis report by Future Market Insights shows that the global sales of the cell and gene therapy manufacturing market reached USD 15.6 billion in 2022.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR Certified, Stevie Award Winner, Greater New York Chamber of Commerce Member) provides deep insight into the drivers driving market demand. FMI is a leading global provider of market intelligence, advisory services, consulting, and events for the packaging, food and beverage, consumer technology, healthcare, industrial, and chemical markets. With a large team of over 400 analysts located around the world, FMI provides global, regional and local expertise on diverse sectors and industry trends in over 110 countries.
inquiry:
Nandini Singh Sawarani
Future Market Insights Co., Ltd.
Christiana Corporate, 200 Continental Drive;
Suite 401, Newark, Delaware – 19713, USA
Phone: +1-845-579-5705
Sales inquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn | Twitter | Blog | YouTube
